We evaluated two biologic markers in the tumor microenvironment through immunohistochemical staining and analysis of tumor-associated macrophages expressing CD163 and tumor-infiltrating lymphocytes expressing PD-1 (Figure 2). This evidence concerns the gene CD163 and neoplasm.